Related Experiment Video
Updated: May 23, 2026
07:35
Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
Pregabalin-associated elevation of clozapine serum levels
Pharmacopsychiatry
|April 5, 2012
Summary
Pregabalin comedication may increase clozapine serum levels in patients with schizophrenia. This dose-dependent effect suggests pregabalin might influence clozapine metabolism, despite its primary renal elimination.
Area of Science:
- Pharmacology
- Psychiatry
- Clinical Toxicology
Background:
- Clozapine is a crucial antipsychotic for treatment-resistant schizophrenia.
- Anxiety is a common comorbidity in schizophrenia, often requiring adjunctive treatment.
- Pregabalin is frequently used for anxiety symptoms.
Observation:
- A patient with schizophrenia experienced elevated clozapine serum levels after initiating pregabalin for anxiety.
- The observed increase in clozapine levels was dose-dependent with respect to pregabalin.
- This occurred despite pregabalin's known pharmacokinetic profile of primarily renal excretion.
Findings:
- The comedication of pregabalin with clozapine led to a significant, dose-dependent rise in clozapine serum concentrations.
- This suggests a potential interaction where pregabalin may affect clozapine's hepatic metabolism or transport.
- This interaction challenges the assumption of exclusive renal elimination influencing drug-drug interactions.
Implications:
- Clinicians should monitor clozapine levels closely when initiating or adjusting pregabalin in patients with schizophrenia.
- This finding necessitates further investigation into the pharmacokinetic and pharmacodynamic interactions between pregabalin and clozapine.
- Understanding this interaction is vital for optimizing treatment efficacy and preventing adverse events in schizophrenia management.
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...